Indeed, previous studies using intrathecal delivery of HGF or HGF overexpression plasmids showed marked delays in ALS disease progression in SOD1G93A mice and rats (Ishigaki et al., 2007; Lee et al., 2019). This evidence concerns the gene HGF and amyotrophic lateral sclerosis.